Literature DB >> 33317767

FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge.

Gonçalo Sousa Pinto1, Matthew Hung2, Funmbi Okoya3, Nilhan Uzman4.   

Abstract

The International Pharmaceutical Federation (FIP), as the global leadership body for pharmacists, pharmaceutical scientists and pharmaceutical educators, coordinated and produced as of January 2020 an international response to the COVID-19 pandemic. FIP's response included professional guidance, a programme of digital events and other resources, as well as advocacy and policy tools to support national pharmacists' associations and academic institutions, as well as individual practitioners, in their response at country level. This article describes the strategy adopted by FIP in collaboration with an international group of experts to support the valuable service that pharmacists and their teams provide to communities throughout the pandemic, and their important contribution to easing the huge strain being placed on health systems around the world.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Coronavirus; Pandemic; Pharmaceutical care; Pharmacists; Pharmacy; Primary health care

Year:  2020        PMID: 33317767     DOI: 10.1016/j.sapharm.2020.07.004

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  10 in total

1.  Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic.

Authors:  Maria Marchese; Angela Heintzman; Mark Pasetka; Flay Charbonneau; Carlo DeAngelis; Christine Peragine
Journal:  J Oncol Pharm Pract       Date:  2021-02-07       Impact factor: 1.809

Review 2.  A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future.

Authors:  Saad Ahmed Sami; Kay Kay Shain Marma; Agnila Chakraborty; Tandra Singha; Ahmed Rakib; Md Giash Uddin; Mohammed Kamrul Hossain; S M Naim Uddin
Journal:  Futur J Pharm Sci       Date:  2021-06-11

3.  The implementation of a FIP guidance for COVID-19: insights from a nationwide survey.

Authors:  Zhan-Miao Yi; Zai-Wei Song; Xin-Ya Li; Yang Hu; Yin-Chu Cheng; Guan-Ru Wang; Rong-Sheng Zhao
Journal:  Ann Transl Med       Date:  2021-09

4.  Exploring the impact of the United States-based accreditation council for pharmacy education certification on pharmacy education outside the United States.

Authors:  Omar Attarabeen; Fadi Alkhateeb; Reza Karimi
Journal:  Saudi Pharm J       Date:  2021-12-31       Impact factor: 4.562

5.  Pharmacy practice architecture challenges in handling COVID-19 pandemic - sharing experience from a Kosovo pharmacy practice.

Authors:  Arianit Jakupi; Arta Basha Jakupi
Journal:  Pharm Pract (Granada)       Date:  2021-12-15

6.  Essential services: Quantifying the contributions of America's pharmacists in COVID-19 clinical interventions.

Authors:  John D Grabenstein
Journal:  J Am Pharm Assoc (2003)       Date:  2022-08-18

Review 7.  Role of Pharmacist in Disaster Management: A Quantitative Content Analysis Approach.

Authors:  Muhammad Ahmer Raza; Shireen Aziz; Misbah Noreen; Shahid Masood Raza
Journal:  Innov Pharm       Date:  2021-09-22

8.  Pharma 4.0: analysis on core competence and digital levelling implementation in pharmaceutical industry in Indonesia.

Authors:  N Nurlaela Arief; Aurik Gustomo; M Rahman Roestan; Aghnia Nadhira Aliya Putri; Muthya Islamiaty
Journal:  Heliyon       Date:  2022-08-18

Review 9.  Rapid realist review of the role of community pharmacy in the public health response to COVID-19.

Authors:  Ian Maidment; Emma Young; Maura MacPhee; Andrew Booth; Hadar Zaman; Juanita Breen; Andrea Hilton; Tony Kelly; Geoff Wong
Journal:  BMJ Open       Date:  2021-06-16       Impact factor: 2.692

10.  The voices of community pharmacists during the COVID-19 pandemic in Puerto Rico.

Authors:  Georgina Silva-Suárez; Yarelis Alvarado Reyes; Ana Hernandez-Diaz; Keysha Rodriguez Ramirez; Frances M Colón-Pratts
Journal:  J Am Pharm Assoc (2003)       Date:  2021-07-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.